カテゴリー： Market Monitor Global, 世界, 医療/バイオ

軟部組織生物製剤の世界市場見通し2023年-2029年

◆英語タイトル：Soft Tissue Biologics Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8005 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Soft Tissue Biologics Market 調査レポートは次の情報を含め、グローバルにおけるの軟部組織生物製剤市場規模と予測を収録しています。・世界の軟部組織生物製剤市場：売上、2018年-2023年、2024年-2029年
・世界の軟部組織生物製剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の軟部組織生物製剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「手根筋軟部組織」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

軟部組織生物製剤のグローバル主要企業は、AlloSource、 Arthrex、 ConMed、 LifeNet Health、 Smith & Nephew、 Stryker、 Surgalign Spine Technologies、 Zimmer Biometなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、軟部組織生物製剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の軟部組織生物製剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の軟部組織生物製剤市場：タイプ別市場シェア、2022年
・手根筋軟部組織、肘部軟部組織、足底筋膜軟部組織、腓腹筋モリス軟部組織、足根管軟部組織、その他

世界の軟部組織生物製剤市場：用途別、2018年-2023年、2024年-2029年
世界の軟部組織生物製剤市場：用途別市場シェア、2022年
・総合病院、専門クリニック、その他

世界の軟部組織生物製剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の軟部組織生物製剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における軟部組織生物製剤のグローバル売上、2018年-2023年
・主要企業における軟部組織生物製剤のグローバル売上シェア、2022年
・主要企業における軟部組織生物製剤のグローバル販売量、2018年-2023年
・主要企業における軟部組織生物製剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AlloSource、 Arthrex、 ConMed、 LifeNet Health、 Smith & Nephew、 Stryker、 Surgalign Spine Technologies、 Zimmer Biomet

*************************************************************

・調査・分析レポートの概要
軟部組織生物製剤市場の定義
市場セグメント
世界の軟部組織生物製剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の軟部組織生物製剤市場規模
世界の軟部組織生物製剤市場規模：2022年 VS 2029年
世界の軟部組織生物製剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの軟部組織生物製剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の軟部組織生物製剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：手根筋軟部組織、肘部軟部組織、足底筋膜軟部組織、腓腹筋モリス軟部組織、足根管軟部組織、その他
軟部組織生物製剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：総合病院、専門クリニック、その他
軟部組織生物製剤の用途別グローバル売上・予測

・地域別市場分析
地域別軟部組織生物製剤市場規模 2022年と2029年
地域別軟部組織生物製剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AlloSource、 Arthrex、 ConMed、 LifeNet Health、 Smith & Nephew、 Stryker、 Surgalign Spine Technologies、 Zimmer Biomet
...

This report aims to provide a comprehensive presentation of the global market for Soft Tissue Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Tissue Biologics. This report contains market size and forecasts of Soft Tissue Biologics in global, including the following market information:
Global Soft Tissue Biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Soft Tissue Biologics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Soft Tissue Biologics companies in 2022 (%)
The global Soft Tissue Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Carpal Soft Tissue Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Soft Tissue Biologics include AlloSource, Arthrex, ConMed, LifeNet Health, Smith & Nephew, Stryker, Surgalign Spine Technologies and Zimmer Biomet, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Soft Tissue Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Soft Tissue Biologics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Soft Tissue Biologics Market Segment Percentages, by Type, 2022 (%)
Carpal Soft Tissue
Cubital Soft Tissue
Plantar Fascia Soft Tissue
Gastrocnemius Mollis Soft Tissue
Tarsal Tunnel Soft Tissue
Others
Global Soft Tissue Biologics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Soft Tissue Biologics Market Segment Percentages, by Application, 2022 (%)
General Hospitals
Speciality Clinics
Others
Global Soft Tissue Biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Soft Tissue Biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Soft Tissue Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Soft Tissue Biologics revenues share in global market, 2022 (%)
Key companies Soft Tissue Biologics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Soft Tissue Biologics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AlloSource
Arthrex
ConMed
LifeNet Health
Smith & Nephew
Stryker
Surgalign Spine Technologies
Zimmer Biomet
Outline of Major Chapters:
Chapter 1: Introduces the definition of Soft Tissue Biologics, market overview.
Chapter 2: Global Soft Tissue Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Soft Tissue Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Soft Tissue Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Soft Tissue Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Soft Tissue Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Soft Tissue Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Soft Tissue Biologics Overall Market Size
2.1 Global Soft Tissue Biologics Market Size: 2022 VS 2029
2.2 Global Soft Tissue Biologics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Soft Tissue Biologics Sales: 2018-2029
3 Company Landscape
3.1 Top Soft Tissue Biologics Players in Global Market
3.2 Top Global Soft Tissue Biologics Companies Ranked by Revenue
3.3 Global Soft Tissue Biologics Revenue by Companies
3.4 Global Soft Tissue Biologics Sales by Companies
3.5 Global Soft Tissue Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Soft Tissue Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Soft Tissue Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Soft Tissue Biologics Players in Global Market
3.8.1 List of Global Tier 1 Soft Tissue Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Soft Tissue Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Soft Tissue Biologics Market Size Markets, 2022 & 2029
4.1.2 Carpal Soft Tissue
4.1.3 Cubital Soft Tissue
4.1.4 Plantar Fascia Soft Tissue
4.1.5 Gastrocnemius Mollis Soft Tissue
4.1.6 Tarsal Tunnel Soft Tissue
4.1.7 Others
4.2 By Type – Global Soft Tissue Biologics Revenue & Forecasts
4.2.1 By Type – Global Soft Tissue Biologics Revenue, 2018-2023
4.2.2 By Type – Global Soft Tissue Biologics Revenue, 2024-2029
4.2.3 By Type – Global Soft Tissue Biologics Revenue Market Share, 2018-2029
4.3 By Type – Global Soft Tissue Biologics Sales & Forecasts
4.3.1 By Type – Global Soft Tissue Biologics Sales, 2018-2023
4.3.2 By Type – Global Soft Tissue Biologics Sales, 2024-2029
4.3.3 By Type – Global Soft Tissue Biologics Sales Market Share, 2018-2029
4.4 By Type – Global Soft Tissue Biologics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Soft Tissue Biologics Market Size, 2022 & 2029
5.1.2 General Hospitals
5.1.3 Speciality Clinics
5.1.4 Others
5.2 By Application – Global Soft Tissue Biologics Revenue & Forecasts
5.2.1 By Application – Global Soft Tissue Biologics Revenue, 2018-2023
5.2.2 By Application – Global Soft Tissue Biologics Revenue, 2024-2029
5.2.3 By Application – Global Soft Tissue Biologics Revenue Market Share, 2018-2029
5.3 By Application – Global Soft Tissue Biologics Sales & Forecasts
5.3.1 By Application – Global Soft Tissue Biologics Sales, 2018-2023
5.3.2 By Application – Global Soft Tissue Biologics Sales, 2024-2029
5.3.3 By Application – Global Soft Tissue Biologics Sales Market Share, 2018-2029
5.4 By Application – Global Soft Tissue Biologics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Soft Tissue Biologics Market Size, 2022 & 2029
6.2 By Region – Global Soft Tissue Biologics Revenue & Forecasts
6.2.1 By Region – Global Soft Tissue Biologics Revenue, 2018-2023
6.2.2 By Region – Global Soft Tissue Biologics Revenue, 2024-2029
6.2.3 By Region – Global Soft Tissue Biologics Revenue Market Share, 2018-2029
6.3 By Region – Global Soft Tissue Biologics Sales & Forecasts
6.3.1 By Region – Global Soft Tissue Biologics Sales, 2018-2023
6.3.2 By Region – Global Soft Tissue Biologics Sales, 2024-2029
6.3.3 By Region – Global Soft Tissue Biologics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Soft Tissue Biologics Revenue, 2018-2029
6.4.2 By Country – North America Soft Tissue Biologics Sales, 2018-2029
6.4.3 US Soft Tissue Biologics Market Size, 2018-2029
6.4.4 Canada Soft Tissue Biologics Market Size, 2018-2029
6.4.5 Mexico Soft Tissue Biologics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Soft Tissue Biologics Revenue, 2018-2029
6.5.2 By Country – Europe Soft Tissue Biologics Sales, 2018-2029
6.5.3 Germany Soft Tissue Biologics Market Size, 2018-2029
6.5.4 France Soft Tissue Biologics Market Size, 2018-2029
6.5.5 U.K. Soft Tissue Biologics Market Size, 2018-2029
6.5.6 Italy Soft Tissue Biologics Market Size, 2018-2029
6.5.7 Russia Soft Tissue Biologics Market Size, 2018-2029
6.5.8 Nordic Countries Soft Tissue Biologics Market Size, 2018-2029
6.5.9 Benelux Soft Tissue Biologics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Soft Tissue Biologics Revenue, 2018-2029
6.6.2 By Region – Asia Soft Tissue Biologics Sales, 2018-2029
6.6.3 China Soft Tissue Biologics Market Size, 2018-2029
6.6.4 Japan Soft Tissue Biologics Market Size, 2018-2029
6.6.5 South Korea Soft Tissue Biologics Market Size, 2018-2029
6.6.6 Southeast Asia Soft Tissue Biologics Market Size, 2018-2029
6.6.7 India Soft Tissue Biologics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Soft Tissue Biologics Revenue, 2018-2029
6.7.2 By Country – South America Soft Tissue Biologics Sales, 2018-2029
6.7.3 Brazil Soft Tissue Biologics Market Size, 2018-2029
6.7.4 Argentina Soft Tissue Biologics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Soft Tissue Biologics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Soft Tissue Biologics Sales, 2018-2029
6.8.3 Turkey Soft Tissue Biologics Market Size, 2018-2029
6.8.4 Israel Soft Tissue Biologics Market Size, 2018-2029
6.8.5 Saudi Arabia Soft Tissue Biologics Market Size, 2018-2029
6.8.6 UAE Soft Tissue Biologics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AlloSource
7.1.1 AlloSource Company Summary
7.1.2 AlloSource Business Overview
7.1.3 AlloSource Soft Tissue Biologics Major Product Offerings
7.1.4 AlloSource Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.1.5 AlloSource Key News & Latest Developments
7.2 Arthrex
7.2.1 Arthrex Company Summary
7.2.2 Arthrex Business Overview
7.2.3 Arthrex Soft Tissue Biologics Major Product Offerings
7.2.4 Arthrex Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.2.5 Arthrex Key News & Latest Developments
7.3 ConMed
7.3.1 ConMed Company Summary
7.3.2 ConMed Business Overview
7.3.3 ConMed Soft Tissue Biologics Major Product Offerings
7.3.4 ConMed Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.3.5 ConMed Key News & Latest Developments
7.4 LifeNet Health
7.4.1 LifeNet Health Company Summary
7.4.2 LifeNet Health Business Overview
7.4.3 LifeNet Health Soft Tissue Biologics Major Product Offerings
7.4.4 LifeNet Health Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.4.5 LifeNet Health Key News & Latest Developments
7.5 Smith & Nephew
7.5.1 Smith & Nephew Company Summary
7.5.2 Smith & Nephew Business Overview
7.5.3 Smith & Nephew Soft Tissue Biologics Major Product Offerings
7.5.4 Smith & Nephew Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Smith & Nephew Key News & Latest Developments
7.6 Stryker
7.6.1 Stryker Company Summary
7.6.2 Stryker Business Overview
7.6.3 Stryker Soft Tissue Biologics Major Product Offerings
7.6.4 Stryker Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Stryker Key News & Latest Developments
7.7 Surgalign Spine Technologies
7.7.1 Surgalign Spine Technologies Company Summary
7.7.2 Surgalign Spine Technologies Business Overview
7.7.3 Surgalign Spine Technologies Soft Tissue Biologics Major Product Offerings
7.7.4 Surgalign Spine Technologies Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Surgalign Spine Technologies Key News & Latest Developments
7.8 Zimmer Biomet
7.8.1 Zimmer Biomet Company Summary
7.8.2 Zimmer Biomet Business Overview
7.8.3 Zimmer Biomet Soft Tissue Biologics Major Product Offerings
7.8.4 Zimmer Biomet Soft Tissue Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Zimmer Biomet Key News & Latest Developments
8 Global Soft Tissue Biologics Production Capacity, Analysis
8.1 Global Soft Tissue Biologics Production Capacity, 2018-2029
8.2 Soft Tissue Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Soft Tissue Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Soft Tissue Biologics Supply Chain Analysis
10.1 Soft Tissue Biologics Industry Value Chain
10.2 Soft Tissue Biologics Upstream Market
10.3 Soft Tissue Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Soft Tissue Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Soft Tissue Biologics in Global Market
Table 2. Top Soft Tissue Biologics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Soft Tissue Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Soft Tissue Biologics Revenue Share by Companies, 2018-2023
Table 5. Global Soft Tissue Biologics Sales by Companies, (K Units), 2018-2023
Table 6. Global Soft Tissue Biologics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Soft Tissue Biologics Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Soft Tissue Biologics Product Type
Table 9. List of Global Tier 1 Soft Tissue Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Soft Tissue Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Soft Tissue Biologics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Soft Tissue Biologics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Soft Tissue Biologics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Soft Tissue Biologics Sales (K Units), 2018-2023
Table 15. By Type - Global Soft Tissue Biologics Sales (K Units), 2024-2029
Table 16. By Application – Global Soft Tissue Biologics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Soft Tissue Biologics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Soft Tissue Biologics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Soft Tissue Biologics Sales (K Units), 2018-2023
Table 20. By Application - Global Soft Tissue Biologics Sales (K Units), 2024-2029
Table 21. By Region – Global Soft Tissue Biologics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Soft Tissue Biologics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Soft Tissue Biologics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Soft Tissue Biologics Sales (K Units), 2018-2023
Table 25. By Region - Global Soft Tissue Biologics Sales (K Units), 2024-2029
Table 26. By Country - North America Soft Tissue Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Soft Tissue Biologics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Soft Tissue Biologics Sales, (K Units), 2018-2023
Table 29. By Country - North America Soft Tissue Biologics Sales, (K Units), 2024-2029
Table 30. By Country - Europe Soft Tissue Biologics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Soft Tissue Biologics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Soft Tissue Biologics Sales, (K Units), 2018-2023
Table 33. By Country - Europe Soft Tissue Biologics Sales, (K Units), 2024-2029
Table 34. By Region - Asia Soft Tissue Biologics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Soft Tissue Biologics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Soft Tissue Biologics Sales, (K Units), 2018-2023
Table 37. By Region - Asia Soft Tissue Biologics Sales, (K Units), 2024-2029
Table 38. By Country - South America Soft Tissue Biologics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Soft Tissue Biologics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Soft Tissue Biologics Sales, (K Units), 2018-2023
Table 41. By Country - South America Soft Tissue Biologics Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Soft Tissue Biologics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Soft Tissue Biologics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Soft Tissue Biologics Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Soft Tissue Biologics Sales, (K Units), 2024-2029
Table 46. AlloSource Company Summary
Table 47. AlloSource Soft Tissue Biologics Product Offerings
Table 48. AlloSource Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AlloSource Key News & Latest Developments
Table 50. Arthrex Company Summary
Table 51. Arthrex Soft Tissue Biologics Product Offerings
Table 52. Arthrex Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Arthrex Key News & Latest Developments
Table 54. ConMed Company Summary
Table 55. ConMed Soft Tissue Biologics Product Offerings
Table 56. ConMed Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. ConMed Key News & Latest Developments
Table 58. LifeNet Health Company Summary
Table 59. LifeNet Health Soft Tissue Biologics Product Offerings
Table 60. LifeNet Health Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. LifeNet Health Key News & Latest Developments
Table 62. Smith & Nephew Company Summary
Table 63. Smith & Nephew Soft Tissue Biologics Product Offerings
Table 64. Smith & Nephew Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Smith & Nephew Key News & Latest Developments
Table 66. Stryker Company Summary
Table 67. Stryker Soft Tissue Biologics Product Offerings
Table 68. Stryker Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Stryker Key News & Latest Developments
Table 70. Surgalign Spine Technologies Company Summary
Table 71. Surgalign Spine Technologies Soft Tissue Biologics Product Offerings
Table 72. Surgalign Spine Technologies Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Surgalign Spine Technologies Key News & Latest Developments
Table 74. Zimmer Biomet Company Summary
Table 75. Zimmer Biomet Soft Tissue Biologics Product Offerings
Table 76. Zimmer Biomet Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Zimmer Biomet Key News & Latest Developments
Table 78. Soft Tissue Biologics Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Soft Tissue Biologics Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Soft Tissue Biologics Production by Region, 2018-2023 (K Units)
Table 81. Global Soft Tissue Biologics Production by Region, 2024-2029 (K Units)
Table 82. Soft Tissue Biologics Market Opportunities & Trends in Global Market
Table 83. Soft Tissue Biologics Market Drivers in Global Market
Table 84. Soft Tissue Biologics Market Restraints in Global Market
Table 85. Soft Tissue Biologics Raw Materials
Table 86. Soft Tissue Biologics Raw Materials Suppliers in Global Market
Table 87. Typical Soft Tissue Biologics Downstream
Table 88. Soft Tissue Biologics Downstream Clients in Global Market
Table 89. Soft Tissue Biologics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Soft Tissue Biologics Segment by Type in 2022
Figure 2. Soft Tissue Biologics Segment by Application in 2022
Figure 3. Global Soft Tissue Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Soft Tissue Biologics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Soft Tissue Biologics Revenue, 2018-2029 (US$, Mn)
Figure 7. Soft Tissue Biologics Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Soft Tissue Biologics Revenue in 2022
Figure 9. By Type - Global Soft Tissue Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 12. By Type - Global Soft Tissue Biologics Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Soft Tissue Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 16. By Application - Global Soft Tissue Biologics Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Soft Tissue Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Soft Tissue Biologics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 21. By Country - North America Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 23. US Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 28. Germany Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 29. France Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 37. China Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 41. India Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 44. Brazil Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Soft Tissue Biologics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Soft Tissue Biologics Sales Market Share, 2018-2029
Figure 48. Turkey Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Soft Tissue Biologics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Soft Tissue Biologics Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Soft Tissue Biologics by Region, 2022 VS 2029
Figure 54. Soft Tissue Biologics Industry Value Chain
Figure 55. Marketing Channels

※参考情報

軟部組織生物製剤について、その概要や特徴、種類、用途、関連技術などを詳しく解説いたします。

軟部組織生物製剤とは、主に人体の柔らかい組織、すなわち筋肉、皮膚、脂肪、腱、靭帯などに関連した治療や再生を目的とする生物由来の材料や製剤を指します。これらの製剤は、主に外科手術や整形外科、スポーツ医学、美容医療などの分野で用いられます。軟部組織は広範な体の部位に存在し、これらの組織が損傷した際や機能不全を起こした際に、その修復や再生を促進することが求められます。

軟部組織生物製剤の特徴の一つは、その生物由来の成分から得られることです。例えば、コラーゲン、ヒアルロン酸、成長因子、幹細胞など、多様な生物成分が含まれており、これらは自然な治癒過程を模倣または促進する働きを持っています。また、これらの製剤は、体内での生体適合性が高く、アレルギー反応や拒絶反応を引き起こすリスクが相対的に低い点も重要です。

軟部組織生物製剤の種類には、以下のようなものがあります。まず、コラーゲン製剤は、皮膚の再生や傷の治癒において重要な役割を果たします。コラーゲンは、皮膚や結合組織の主要な構成成分であり、その補充により皮膚の弾力性が改善されます。次に、ヒアルロン酸製剤は、関節や皮膚において水分保持能力を高め、滑らかさを保つために使用されます。整形外科では、関節の動きをスムーズにするための注射剤として利用されることが多いです。

成長因子を用いた製剤も軟部組織生物製剤の一部です。これらは、細胞の増殖や分化を促進する物質であり、特に組織の再生過程において重要です。たとえば、トランスフォーミング成長因子ベータ（TGF-β）や血小板由来成長因子（PDGF）などが過去の研究において利用されています。これらは、創傷治癒や組織再生において非常に有効です。

さらに、幹細胞を利用した軟部組織生物製剤は、最先端の研究分野です。幹細胞は、高い自己再生能力を持ち、様々な細胞に分化する可能性を有します。脂肪由来幹細胞（SVF）や骨髄由来幹細胞（BMSC）などを用いた治療は、軟部組織の修復や再生において大きな可能性を秘めています。

軟部組織生物製剤の用途は多岐にわたります。整形外科やスポーツ医学の領域では、軟部組織の損傷や炎症に対する治療が主な利用方法です。例えば、スポーツ選手の怪我や関節痛に対して、ヒアルロン酸注射や成長因子を用いた治療が行われます。また、外科手術後の創傷治癒を促進するために、コラーゲン製剤や成長因子を使用するケースもあります。

美容医療においても、軟部組織生物製剤は重要な役割を果たしています。ヒアルロン酸を用いた「 fillers（フィラー）」は人気であり、顔のしわやボリュームの減少を改善するために広く使用されています。コラーゲンや成長因子も、肌の再生や若返りを目的とした治療において重要です。

関連技術として、3Dバイオプリンティングや生体材料の研究が挙げられます。3Dバイオプリンティングは、生体材料と細胞を組み合わせて、軟部組織の構造を再現する技術です。この技術により、より効果的な治療法や製剤が開発される可能性があります。また、ナノテクノロジーを活用した薬物送達システムも、軟部組織生物製剤の効果を向上させる手段として研究が進められています。

今後の展望としては、軟部組織生物製剤の精度や効果をさらに向上させるための研究が期待されます。特に、個々の患者の状態に応じた「パーソナライズドメディスン」への適用は、今後の医療において重要なテーマとなるでしょう。aiやデータ解析技術の進展により、治療効果の予測や製剤の最適化が進むことで、より安全で効果的な治療が実現されることが期待されます。

総じて、軟部組織生物製剤は、組織再生や治療において大きな可能性を秘めた分野です。この領域の研究と技術の進展は、医療の未来を大きく変革する可能性があります。今後、その応用範囲がどのように拡大し、進化していくのか、非常に注目されるところです。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 軟部組織生物製剤の世界市場見通し2023年-2029年(Soft Tissue Biologics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

軟部組織生物製剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp